PENTRAXIN-3 AS A NOVEL CARDIOTOXIC BIOMARKER FOR BREAST CANCER PATIENTS RECEIVING ANTHRACYCLINES AND THE IMPACT OF PHYSICAL ACTIVITY: AN INTERIM REPORT FROM THE EXACT 2.0 TRIAL

Autor: Heinze, S., Kendall, S., Corbett, A., Arya, V., Bortoluzzi, T., Bryson, A., Cheung, D., Eekhoudt, C., Giacomantonio, N., Keats, M., Melvin, J., Mulvagh, S., Pitz, M., Rajda, M., Telles-Langdon, S., Varghese, S., Jassal, D., Grandy, S.
Zdroj: In Canadian Journal of Diabetes November 2023 47(7) Supplement:S46-S47
Databáze: ScienceDirect
Externí odkaz: